CLRB(CLRB)
CLRB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $4M | $7M | $46M | $99M | $152M |
| Low | $4M | $7M | $46M | $99M | $152M |
| High | $4M | $7M | $46M | $99M | $152M |
| EBITDA Avg | — | — | — | — | — |
| Low | — | — | — | — | — |
| High | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — |
| Low | — | — | — | — | — |
| High | — | — | — | — | — |
| Net Income Avg | $-5M | $-4M | $-873,786 | $2M | $5M |
| Low | $-7M | $-6M | $-965,077 | $2M | $5M |
| High | $-4M | $-3M | $-782,495 | $2M | $5M |
| EPS Avg | $-2.05 | $-1.60 | $-0.34 | $0.77 | $1.90 |
| Low | $-2.49 | $-2.12 | $-0.37 | $0.77 | $1.90 |
| High | $-1.59 | $-1.08 | $-0.30 | $0.77 | $1.90 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 3 / 2 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $17M | $25M | — | — | — | — |
| Low | $17M | $25M | — | — | — | — |
| High | $17M | $25M | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Net Income Avg | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M |
| Low | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M |
| High | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M |
| EPS Avg | $-0.43 | $-0.45 | $-0.57 | $-0.60 | $-0.60 | $-0.79 |
| Low | $-0.43 | $-0.45 | $-0.57 | $-0.60 | $-0.60 | $-0.79 |
| High | $-0.43 | $-0.45 | $-0.57 | $-0.60 | $-0.60 | $-0.79 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 | — / 1 | — / 1 | — / 1 | — / 1 |